Medicines Healthcare products Regulating Authority: SSRI

Calling all doctors, pharmacists and nurses  involved in the care of patients with depression. Also valuable for clinicians starting out in  psychiatry.

(Selective serotonin reuptake inhibitor) SSRI learning module

The MHRA have just launched a learning module on selective serotonin reuptake inhibitors (SSRI) antidepressants for clinical practitioners.  This self-directed learning package outlines the key risks of this important class of medicines. For each adverse effect, the package outlines:

  • the main features of the adverse effect
  • factors that increase the risk
  • how the risk can be reduced
  • specific treatment for the adverse effect.

A self-assessment exercise, together with full feedback, complements the learning material. SSRI learning module

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s